Anti-KDM4A / JHDM3A / JMJD2A antibody [EPR18466]
- RabMAb
- Recombinant
- KO Validated
- What is this?
Be the first to review this product! Submit a review
|
(13 Publications)
Rabbit Recombinant Monoclonal KDM4A / JHDM3A / JMJD2A antibody. Suitable for IP, WB, IHC-P and reacts with Human, Mouse, Rat samples. Cited in 13 publications.
View Alternative Names
JHDM3A, JMJD2, JMJD2A, KIAA0677, KDM4A, Lysine-specific demethylase 4A, JmjC domain-containing histone demethylation protein 3A, Jumonji domain-containing protein 2A, [histone H3]-trimethyl-L-lysine(36) demethylase 4A, [histone H3]-trimethyl-L-lysine(9) demethylase 4A
- IHC-P
Supplier Data
Immunohistochemistry (Formalin/PFA-fixed paraffin-embedded sections) - Anti-KDM4A / JHDM3A / JMJD2A antibody [EPR18466] (AB191433)
Immunohistochemical analysis of paraffin-embedded human colon tissue labeling KDM4A / JHDM3A / JMJD2A with ab191433 at 1/250 dilution followed by Goat Anti-Rabbit IgG H&L (HRP) (ab97051) at 1/500 dilution.
Nuclear staining in epithelial cells of human colon is observed.
Counter stained with Hematoxylin.
Secondary antibody only control : Used PBS instead of primary antibody secondary antibody is Goat Anti-Rabbit IgG H&L (HRP) (ab97051) at 1/500 dilution.
Perform heat mediated antigen retrieval with Tris/EDTA buffer pH 9.0 before commencing with IHC staining protocol.
- IP
Supplier Data
Immunoprecipitation - Anti-KDM4A / JHDM3A / JMJD2A antibody [EPR18466] (AB191433)
KDM4A / JHDM3A / JMJD2A was immunoprecipitated from 1mg of HeLa (Human epithelial cell line from cervix adenocarcinoma) whole cell lysate with ab191433 at 1/80 dilution.
Western blot was performed from the immunoprecipitate using ab191433 at 1/1000 dilution.
VeriBlot for IP Detection Reagent (HRP) (ab131366), was used for detection at 1/10000 dilution.
Lane 1 : HeLa whole cell lysate 10μg (Input).
Lane 2 : ab191433 IP in HeLa whole cell lysate.
Lane 3 : Rabbit monoclonal IgG (ab172730) instead of ab191433 in HeLa whole cell lysate.
Blocking and dilution buffer and concentration : 5% NFDM/TBST.
Exposure time : 3 seconds.
All lanes:
Immunoprecipitation - Anti-KDM4A / JHDM3A / JMJD2A antibody [EPR18466] (ab191433)
Predicted band size: 120 kDa
false
- IHC-P
Supplier Data
Immunohistochemistry (Formalin/PFA-fixed paraffin-embedded sections) - Anti-KDM4A / JHDM3A / JMJD2A antibody [EPR18466] (AB191433)
Immunohistochemical analysis of paraffin-embedded rat colon tissue labeling KDM4A / JHDM3A / JMJD2A with ab191433 at 1/250 dilution followed by Goat Anti-Rabbit IgG H&L (HRP) (ab97051) at 1/500 dilution.
Nuclear staining in epithelial cells of rat colon is observed.
Counter stained with Hematoxylin.
Secondary antibody only control : Used PBS instead of primary antibody secondary antibody is Goat Anti-Rabbit IgG H&L (HRP) (ab97051) at 1/500 dilution.
Perform heat mediated antigen retrieval with Tris/EDTA buffer pH 9.0 before commencing with IHC staining protocol.
- WB
Lab
Western blot - Anti-KDM4A / JHDM3A / JMJD2A antibody [EPR18466] (AB191433)
Lane 1 : Wild-type HAP1 cell lysate (20 μg)
Lane 2 : KDM4A / JHDM3A / JMJD2A knockout HAP1 cell lysate (20 μg)
Lane 3 : U2OS cell lysate (20 μg)
Lane 4 : PC12 cell lysate (20 μg)
Lanes 1 - 4 : Merged signal (red and green). Green - ab191433 observed at 110 kDa. Red - loading control, ab8245, observed at 37 kDa.
ab191433 was shown to specifically react with KDM4A / JHDM3A / JMJD2A when KDM4A / JHDM3A / JMJD2A knockout samples were used. Wild-type and KDM4A / JHDM3A / JMJD2A knockout samples were subjected to SDS-PAGE. ab191433 and ab8245 (loading control to GAPDH) were diluted 1/500 and 1/10000 respectively and incubated overnight at 4°C. Blots were developed with Goat anti-Rabbit IgG H&L (IRDye® 800CW) preadsorbed (ab216773) and Goat anti-Mouse IgG H&L (IRDye® 680RD) preadsorbed (ab216776) secondary antibodies at 1/10000 dilution for 1 hour at room temperature before imaging.
All lanes:
Western blot - Anti-KDM4A / JHDM3A / JMJD2A antibody [EPR18466] (ab191433)
Predicted band size: 120 kDa
false
- WB
Unknown
Western blot - Anti-KDM4A / JHDM3A / JMJD2A antibody [EPR18466] (AB191433)
Exposure time : Lane 1 : 1 minute; Lane 2 : 3 minutes; Lane 3 and 4 : 1 minute
Blocking/Dilution buffer : 5% NFDM/TBST
Lanes 1 - 3:
Western blot - Anti-KDM4A / JHDM3A / JMJD2A antibody [EPR18466] (ab191433) at 1/5000 dilution
Lane 4:
Anti-MTHFD2 antibody [7] (<a href='/en-us/products/unavailable/mthfd2-antibody-7-ab191443'>ab191443</a>) at 1/5000 dilution
Lane 1:
Human fetal kidney at 10 µg
Lane 2:
HEK-293 (Human epithelial cell line from embryonic kidney) whole cell lysate at 20 µg
Lane 3:
LNCaP (Human prostate cancer cell line) whole cell lysate at 20 µg
Lane 4:
U-2 OS (Human bone osteosarcoma epithelial cell line) whole call lysate at 20 µg
Secondary
Lane 1:
Goat Anti-Rabbit IgG Peroxidase Conjugate, specific to the non-reduced form of IgG at 1/100000 dilution
Lanes 2 - 3:
Western blot - Goat Anti-Rabbit IgG H&L (HRP) (<a href='/en-us/products/secondary-antibodies/goat-rabbit-igg-h-l-hrp-ab97051'>ab97051</a>) at 1/100000 dilution
Lane 4:
Western blot - Goat Anti-Rabbit IgG H&L (HRP) (<a href='/en-us/products/secondary-antibodies/goat-rabbit-igg-h-l-hrp-ab97051'>ab97051</a>) at 1/5000 dilution
Predicted band size: 120 kDa
Observed band size: 150 kDa
true
- WB
Supplier Data
Western blot - Anti-KDM4A / JHDM3A / JMJD2A antibody [EPR18466] (AB191433)
Blocking/Dilution buffer : 5% NFDM/TBST.
All lanes:
Western blot - Anti-KDM4A / JHDM3A / JMJD2A antibody [EPR18466] (ab191433) at 1/5000 dilution
Lane 1:
PC-12 (Rat adrenal gland pheochromocytoma cell line) whole cell lysate at 10 µg
Lane 2:
NIH/3T3 (Mouse embryonic fibroblast cell line) whole cell lysate at 10 µg
Secondary
All lanes:
Western blot - Goat Anti-Rabbit IgG H&L (HRP) (<a href='/en-us/products/secondary-antibodies/goat-rabbit-igg-h-l-hrp-ab97051'>ab97051</a>) at 1/100000 dilution
Predicted band size: 120 kDa,31 kDa
Observed band size: 150 kDa,50 kDa
true
Exposure time: 30s
Related conjugates and formulations (8)
-
Anti-KDM4A / JHDM3A / JMJD2A antibody [EPR18466] - BSA and Azide free
-
519 Alexa Fluor® 488
Alexa Fluor® 488 Anti-KDM4A / JHDM3A / JMJD2A antibody [EPR18466]
-
578 PE
PE Anti-KDM4A / JHDM3A / JMJD2A antibody [EPR18466]
-
660 APC
APC Anti-KDM4A / JHDM3A / JMJD2A antibody [EPR18466]
-
665 Alexa Fluor® 647
Alexa Fluor® 647 Anti-KDM4A / JHDM3A / JMJD2A antibody [EPR18466]
-
617 Alexa Fluor® 594
Alexa Fluor® 594 Anti-KDM4A / JHDM3A / JMJD2A antibody [EPR18466]
-
565 Alexa Fluor® 555
Alexa Fluor® 555 Anti-KDM4A / JHDM3A / JMJD2A antibody [EPR18466]
-
775 Alexa Fluor® 750
Alexa Fluor® 750 Anti-KDM4A / JHDM3A / JMJD2A antibody [EPR18466]
Reactivity data
Product details
Patented technology
Our RabMAb® technology is a patented hybridoma-based technology for making rabbit monoclonal antibodies. For details on our patents, please refer to RabMAb® patents.
What are the advantages of a recombinant monoclonal antibody?
This product is a recombinant monoclonal antibody, which offers several advantages including:
- - High batch-to-batch consistency and reproducibility
- - Improved sensitivity and specificity
- - Long-term security of supply
- - Animal-free batch production
For more information, read more on recombinant antibodies.
Properties and storage information
Form
Purification technique
Storage buffer
Shipped at conditions
Appropriate short-term storage duration
Appropriate short-term storage conditions
Appropriate long-term storage conditions
Aliquoting information
Storage information
Product protocols
- Visit the General protocols
- Visit the Troubleshooting
Target data
Publications (13)
Recent publications for all applications. Explore the full list and refine your search
Acta biochimica et biophysica Sinica : PubMed40999902
2025
Applications
Unspecified application
Species
Unspecified reactive species
iScience 28:111538 PubMed39811655
2025
Applications
Unspecified application
Species
Unspecified reactive species
Environmental toxicology 39:4207-4220 PubMed38727079
2024
Applications
Unspecified application
Species
Unspecified reactive species
Translational oncology 28:101615 PubMed36592610
2023
Applications
Unspecified application
Species
Unspecified reactive species
Cytotechnology 74:579-590 PubMed36238269
2022
Applications
Unspecified application
Species
Unspecified reactive species
Stem cells international 2022:1608806 PubMed35287356
2022
Applications
Unspecified application
Species
Unspecified reactive species
Frontiers in neurology 12:713293 PubMed34664012
2021
Applications
Unspecified application
Species
Unspecified reactive species
Frontiers in cell and developmental biology 9:697614 PubMed34631698
2021
Applications
Unspecified application
Species
Unspecified reactive species
Experimental & molecular medicine 53:1207-1217 PubMed34385569
2021
Applications
Unspecified application
Species
Unspecified reactive species
Molecular cell 81:2148-2165.e9 PubMed33743195
2021
Applications
Unspecified application
Species
Unspecified reactive species
Product promise
Please note: All products are 'FOR RESEARCH USE ONLY. NOT FOR USE IN DIAGNOSTIC OR THERAPEUTIC PROCEDURES'.
For licensing inquiries, please contact partnerships@abcam.com